RE:RE:Anyone have the Short postion PROtrading wrote: I'm thinking about opening a short position at VRX in the $19 CAD But my money is tied up in a real turn around sector.
Based on a doji and a tangible book value of MINUS $90 per share! But I think I'll wait to see if the run continues or not... Charts are mixed but I would say that the US shorts covered in a hurry but it's vulnerable again.
I recently re-opened a short position for VRX @ 19. Everyone forgets how much debt Valeant is currently burried in. With Ackman walking away from VRX, for a loss. I think that speaks for itself. Not to mention the drug exclusivity of VRX's top 10 products running out of time, when generic branding will dwindle away and replace their overpriced drugs with a cheaper product. Jublia looses exclusivity in 2019 which is their #2 product. I believe Xifaxan is 2019 as well. Just my opinion though! GLTA